View source for Sickle Cell Disease


This is a Stub Notice. This page has not been completed. You can work on this page by signing in and going to the <b>Edit</b> tab. Thanks for helping to make PedsAnesthesia.Net Wiki useful.

Go to the [[Main Page]] to see the Topic Outline.

Go to the [[Generalized Suggested Outline]] for information on case-specific details for each page.

Go to the [[Test Page]] for examples on how to use references in the page.

__NOTOC__ __NOEDITSECTION__

[https://pubmed.ncbi.nlm.nih.gov/37205803/ Current Evidence and Rationale to Guide Perioperative Management, Including Transfusion Decisions, in Patients With Sickle Cell Disease]

[[The anaesthetic management of children with sickle cell disease]]

[https://www.nejm.org/doi/full/10.1056/NEJM199507273330402 A Comparison of Conservative and Aggressive Transfusion Regimens in the Perioperative Management of Sickle Cell Disease]

[https://pubs.asahq.org/anesthesiology/article/101/3/766/9209/Sickle-Cell-Disease-and-Anesthesia Sickle Cell Disease and Anesthesia]

[https://www.bjaed.org/article/S2058-5349(18)30103-3/fulltext Anaesthetic management of children with sickle cell disease]

[https://pubmed.ncbi.nlm.nih.gov/36031024/ Special issue: Pediatric pain and sickle cell disease]

Brousse V, Elie C, Benkerrou M, et al. Acute splenic sequestration crisis in sickle cell disease: cohort study of 190 paediatric patients. Br J Haematol. 2012 Mar; 156(5): 643-8. PMID: 22224796

Al-Salem AH. Splenic complications of sickle cell anemia and the role of splenectomy. ISRN Hematol. 2011; 2011: 864257. PMID: 22084706

Kinney TR, Ware RE, Schultz WH, Filston HC. Long-term management of splenic sequestration in children with sickle cell disease. J Pediatr. 1990 Aug; 117(2 Pt 1): 194-9. PMID: 2380816

[https://www.apsf.org/article/preoperative-transfusion-and-sickle-cell-disease-in-the-pediatric-patient/ APSF: Preoperative Transfusion and Sickle Cell Disease in the Pediatric Patient]

Firth PG, McMillan KN, Haberkern CM, Yaster M, Bender MA, Goodwin SR. A survey of perioperative management of sickle cell disease in North America. PaediatrAnaesth 2011;21(1):43-49.

2.            Goodwin SR, Haberkern C, Crawford M, Lerman J, Mancuso T, Yaster M. Sickle cell and anesthesia: do not abandon well-established practices without evidence. Anesthesiology 2005;103(1):205-207.

3.            Vichinsky EP, Haberkern CM, Neumayr L, et al. A comparison of conservative and aggressive transfusion regimens in the perioperative management of sickle cell disease. The Preoperative Transfusion in Sickle Cell Disease Study Group [see comments]. NEnglJMed 1995;333(4):206-213.

4.            Azbell RCG, Lanzkron SM, Desai PC. Current Evidence and Rationale to Guide Perioperative Management, Including Transfusion Decisions, in Patients With Sickle Cell Disease. Anesthesia and analgesia 2023;136(6):1107-1114. (In eng). DOI: 10.1213/ane.0000000000006463.

5.            Baijal RG, Dalal PG, Kanjia M. Preoperative Transfusion and Sickle Cell Disease in the Pediatric Patient. Anesthesia Patient Safety Foundation. 06/2024 (https://www.apsf.org/article/preoperative-transfusion-and-sickle-cell-disease-in-the-pediatric-patient/?utm_source=APSF+Newsletter+Email+-+External&utm_medium=email&utm_campaign=EMAIL_CAMPAIGN_2024_06_01).

6.            Hyder O, Yaster M, Bateman BT, Firth PG. Surgical procedures and outcomes among children with sickle cell disease. Anesthesia and analgesia 2013;117(5):1192-6. (In eng). DOI: 10.1213/ANE.0b013e3182a44d74.

7.            Waldron P, Pegelow C, Neumayr L, et al. Tonsillectomy, adenoidectomy, and myringotomy in sickle cell disease: perioperative morbidity. Preoperative Transfusion in Sickle Cell Disease Study Group. JPediatrHematolOncol 1999;21(2):129-135.

8.            Chou ST, Alsawas M, Fasano RM, et al. American Society of Hematology 2020 guidelines for sickle cell disease: transfusion support. Blood Adv 2020;4(2):327-355. (In eng). DOI: 10.1182/bloodadvances.2019001143.

9.            Salvi PS, Solomon DG, Cowles RA. Preoperative Transfusion and Surgical Outcomes for Children with Sickle Cell Disease. J Am Coll Surg 2022;235(3):530-538. (In eng). DOI: 10.1097/xcs.0000000000000267.

10.         Pignatti M, Zanella S, Borgna-Pignatti C. Can the surgical tourniquet be used in patients with sickle cell disease or trait? A review of the literature. Expert Rev Hematol 2017;10(2):175-182. (In eng). DOI: 10.1080/17474086.2017.1273765.

Howard J, Hart N, Roberts-Harewood M, et al. Guideline on the management of acute chest syndrome in sickle cell disease. Br J Haematol. 2015 May; 169(4): 492-505. PMID: 25824256

Delatte SJ, Hebra A, Tagge EP, Jackson S, Jacques K, Othersen HB Jr. Acute chest syndrome in the postoperative sickle cell patient. J Pediatr Surg. 1999 Jan; 34(1): 188-91; discussion 191-2. PMID: 10022169

Sohn E. Ease the Pain: The excruciating pain of sickle cell disease is difficult to prevent or treat. Researchers are working on new ways to provide relief. Sci Am 2024; 331(3): 94.

Reardon S. New Treatments for Sickle Cell Disease: After years of little progress, new therapies to treat or even cure the disease are reaching patients. Sci Am 2024; 331(3): 85.

Smith WR, Penberthy LT, Bovbjerg VE, et al. Daily assessment of pain in adults with sickle cell disease. Annals of internal medicine 2008; 148(2): 94-101.

Smith WR, Scherer M. Sickle-Cell Pain: Advances in Epidemiology and Etiology. Hematology 2010; 2010(1): 409-15.

Dampier C, Ely E, Brodecki D, O'Neal P. Home management of pain in sickle cell disease: a daily diary study in children and adolescents. J Pediatr Hematol Oncol 2002; 24(8): 643-7.

Brandow AM, Brousseau DC, Panepinto JA. Postdischarge pain, functional limitations and impact on caregivers of children with sickle cell disease treated for painful events. Br J Haematol 2009; 144(5): 782-8.

Ballas SK, Lusardi M. Hospital readmission for adult acute sickle cell painful episodes: frequency, etiology, and prognostic significance. Am J Hematol 2005; 79(1): 17-25.

Dampier CD, Telen MJ, Wun T, et al. A randomized clinical trial of the efficacy and safety of rivipansel for sickle cell vaso-occlusive crisis. Blood 2023; 141(2): 168-79.

Karimi M, Bahadoram M, Mafakher L, Rastegar M. Impact of Imatinib on reducing the painful crisis in patients with sickle cell disease. Hematol Transfus Cell Ther 2024; 46(4): 387-92.

"First Patient Begins Newly Approved Sickle Cell Gene Therapy." The New York Times, May 6, 2024.

[https://onlinelibrary.wiley.com/doi/10.1002/pbc.31458 Safety and Tolerability of Intravenous Lidocaine Infusions as Opioid Adjunct for Children Hospitalized With Sickle Cell Vaso-Occlusive Pain]

[https://annalsofintensivecare.springeropen.com/articles/10.1186/s13613-025-01479-3 Guidelines for the management of emergencies and critical illness in pediatric and adult patients with sickle cell disease]